Results 161 to 170 of about 14,827 (208)

Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trial. [PDF]

Brain
Othman MH, Toury-Puel AG, Hansen KIT, Amiri M, Zarifkar P, Peinkhofer C, Stückler SG, Olsen MH, Bjerregaard J, Smitt M, Magnussen AS, Forsse A, Møller J, Nielsen MKK, Jessen CH, Hassager C, Hyttel-Sørensen S, Perner A, Møller MH, Møller-Sørensen PH, Hauerberg J, Birkeland P, Sigurdsson ST, Wamberg CA, Itenov TS, Meyhoff CS, Møller K, Andersen TS, Kjaergaard J, Kondziella D.   +29 more
europepmc   +1 more source

Glucuronidation of apomorphine

Life Sciences, 2000
Apomorphine, a dopaminergic receptor agonist, is largely used in the therapy of Parkinson's disease. In this study, we characterized the glucuronidation of apomorphine and other catechols in rat liver and brain microsomes, using UDP-[U-14C]glucuronic acid and separation of the glucuronides formed by a thin layer chromatographic method.
R S, El-Bachá, S, Leclerc, P, Netter, J, Magdalou, A, Minn   +4 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacology and Neurochemistry of Apomorphine

1978
Publisher Summary This chapter discusses the pharmacology and neurochemistry of apomorphine. Apomorphine was first employed as a powerful emetic agent. Apomorphine can be obtained by the acid-catalyzed rearrangement of morphine and by total synthesis.
DI CHIARA, GAETANO, GESSA GL
openaire   +2 more sources

Apomorphine

Reactions Weekly, 2020
  +5 more sources

Apomorphine

Reactions Weekly, 2021
openaire   +2 more sources

Apomorphine

Reactions Weekly, 2023
openaire   +1 more source

Apomorphine

Reactions Weekly, 2019
  +4 more sources

Apomorphine.

Reactions Weekly, 2011
openaire   +2 more sources

Apomorphine

Reactions Weekly, 2015
openaire   +2 more sources